These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 8668288)

  • 1. [Clinical evaluation of cinnoxicam 30 mg in patients with osteoarthrosis. A double-blind controlled study].
    Bestetti F
    Minerva Med; 1996 Mar; 87(3):117-22. PubMed ID: 8668288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical evaluation of 30 mg cinnoxicam in patients with osteoarthrosis. Double blind controlled trial].
    Peretti G
    Minerva Med; 1996 Apr; 87(4):155-60. PubMed ID: 8700339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Evaluation of a new non-steroidal anti-inflammatory agent in degenerative osteo-articular pathology].
    Caniggia M; Morreale P
    Minerva Med; 1991 Jun; 82(6):399-404. PubMed ID: 2067714
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A new non-steroidal anti-inflammatory drug pirprofen (rengasil) in the treatment of rheumatoid arthritis and osteoarthrosis].
    Sigidin IaA; Pokryshkin VI
    Ter Arkh; 1987; 59(4):73-6. PubMed ID: 2954253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A clinical trial comparing a new NSAID (droxicam) and piroxicam in spinal osteoarthritis.
    Bohl D; Gausmann H; Vorberg G; Sánchez J; García-Barbal R; Sarti JF; Harrison FJ
    Int J Clin Pharmacol Ther Toxicol; 1990 Oct; 28(10):416-9. PubMed ID: 2258250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Double-blind, placebo-controlled, randomized clinical trial of sublingual or intramuscular piroxicam in the treatment of renal colic. A comparative study.
    Altay B; Horasanli K; Sarica K; Tanriverdi O; Kendirci M; Miroglu C
    Urol Int; 2007; 79(1):73-5. PubMed ID: 17627173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Piroxicam therapy: a double blind, randomized, multicenter study comparing 2 versus 4 week treatment in patients with painful knee osteoarthritis with effusion.
    Ravaud P; Auleley GR; Ayral X; Marre JP; Amor B
    J Rheumatol; 1998 Dec; 25(12):2425-31. PubMed ID: 9858440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and efficacy of a new 3.3 g b.i.d. tablet formulation in patients with mild-to-moderately-active ulcerative colitis: a multicenter, randomized, double-blind, placebo-controlled study.
    Scherl EJ; Pruitt R; Gordon GL; Lamet M; Shaw A; Huang S; Mareya S; Forbes WP
    Am J Gastroenterol; 2009 Jun; 104(6):1452-9. PubMed ID: 19491859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Piroxicam fast-dissolving dosage form vs diclofenac sodium in the treatment of acute renal colic: a double-blind controlled trial.
    Supervía A; Pedro-Botet J; Nogués X; Echarte JL; Mínguez S; Iglesias ML; Gelabert A
    Br J Urol; 1998 Jan; 81(1):27-30. PubMed ID: 9467472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A multicenter, randomized, double blind study comparing lornoxicam with diclofenac in osteoarthritis.
    Kidd B; Frenzel W
    J Rheumatol; 1996 Sep; 23(9):1605-11. PubMed ID: 8877932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of osteoarthritis with piroxicam.
    Eur J Rheumatol Inflamm; 1983; 6(1):73-83. PubMed ID: 6345167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Fast-dissolving sublingual tablets of piroxicam versus naproxen in the treatment of recurrent acute osteoarthrosis. Multicenter clinical trial].
    Consoli G; Covelli M; Di Matteo L; Marcolongo R; Tirri G; La Montagna G; Pipitone V
    Minerva Med; 1994 Mar; 85(3):89-96. PubMed ID: 8196849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Analgesic activity of cinnoxicam. Findings of clinical sensimetry].
    Biasi G; Piazzini M; Fioravanti A; Francioni C; Marcolongo R
    Clin Ter; 1989 Dec; 131(5):315-9. PubMed ID: 2532585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Norwegian multicenter study.
    Husby G
    Am J Med; 1986 Nov; 81(5B):6-10. PubMed ID: 3538870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative efficacy and tolerability of nimesulide and piroxicam in osteoarthritis with specific reference to chondroprotection: a double blind randomised study.
    Roy V; Gupta U; Sharma S; Dhaon BK; Singh NP; Gulati P
    J Indian Med Assoc; 1999 Oct; 97(10):442-5. PubMed ID: 10638109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic activity, clinical and gastric tolerance of 20mg daily dose of droxicam in comparison with piroxicam in patients with degenerative joint disease.
    Schüetz E; Sánchez J; García-Barbal J; Sarti JF; Reuter C; Harrison FJ
    Eur J Rheumatol Inflamm; 1991; 11(4):21-8. PubMed ID: 1365486
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical experience with the use of piroxicam in fast-dissolving sublingual capsules in acute recurrent osteoarthritis].
    Minisola G; Bancheri C; Bogliolo A; Brundisini B; Gospodinoff L; Lucentini L; Porzio F; Perpignano G
    Clin Ter; 1993 Dec; 143(6):519-29. PubMed ID: 8306576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the efficacy and safety of etodolac and piroxicam in patients with rheumatoid arthritis. Etodolac Study 326 Rheumatoid Arthritis Investigators Group.
    Lightfoot R
    J Rheumatol Suppl; 1997 Feb; 47():10-6. PubMed ID: 9035015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lornoxicam in clinical practice.
    Berry H; Ollier S
    Postgrad Med J; 1990; 66 Suppl 4():S41-5. PubMed ID: 2284220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Double-blind evaluation of piroxicam and indomethacin in the treatment of inflammation following oral surgery.
    Ohnishi M; Kawai T; Ogawa N
    Eur J Rheumatol Inflamm; 1983; 6(3):259-65. PubMed ID: 6391930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.